Atrioesophageal Fistula Clinical Presentation, Procedural Characteristics, Diagnostic Investigations, and Treatment Outcomes
Hui-Chen Han, Francis J Ha, Prashanthan Sanders, Ryan Spencer, Andrew W Teh, David O'Donnell, Omar Farouque, Han S Lim
Circulation Arrhythmia and Electrophysiology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2017
BACKGROUND: Percutaneous or surgical ablation are increasingly used worldwide in the management of atrial fibrillation. The development of atrioesophageal fistula (AEF) is among the most serious and lethal complications of atrial fibrillation ablation. We sought to characterize the clinical presentation, procedural characteristics, diagnostic investigations, and treatment outcomes of all reported cases of AEF. METHODS AND RESULTS: Electronic searches were conducted in PubMed and Embase for English scientific literature articles. Out of 628 references, 120 cases of AEF were identified using various ablation modalities. Clinical presentation occurred between 0 and 60 days postablation (median ..View full abstract
Dr Lim reports having received research funding from St Jude Medical and is supported by the Neil Hamilton Farley Early Career Fellowship from the National Health and Medical Research Council of Australia. Dr Sanders reports having served on the advisory board of Biosense-Webster, Medtronic, St Jude Medical, Sanofi-Aventis and Merck, Sharpe and Dohme. Dr Sanders reports having received lecture fees from Biosense-Webster, Medtronic, St Jude Medical, Boston Scientific, Merck, Sharpe and Dohme, Biotronik and Sanofi-Aventis. Dr Sanders reports having received research funding from Medtronic, St Jude Medical, Boston Scientific, Biotronik and Sorin. The other authors report no conflicts.